These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

829 related articles for article (PubMed ID: 31982429)

  • 1. Cathelicidin aggravates myocardial ischemia/reperfusion injury via activating TLR4 signaling and P2X
    Wu Y; Zhang Y; Zhang J; Zhai T; Hu J; Luo H; Zhou H; Zhang Q; Zhou Z; Liu F
    J Mol Cell Cardiol; 2020 Feb; 139():75-86. PubMed ID: 31982429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury.
    Liu Y; Lian K; Zhang L; Wang R; Yi F; Gao C; Xin C; Zhu D; Li Y; Yan W; Xiong L; Gao E; Wang H; Tao L
    Basic Res Cardiol; 2014; 109(5):415. PubMed ID: 25015733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.
    Sandanger Ø; Ranheim T; Vinge LE; Bliksøen M; Alfsnes K; Finsen AV; Dahl CP; Askevold ET; Florholmen G; Christensen G; Fitzgerald KA; Lien E; Valen G; Espevik T; Aukrust P; Yndestad A
    Cardiovasc Res; 2013 Jul; 99(1):164-74. PubMed ID: 23580606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway.
    Dai Y; Wang S; Chang S; Ren D; Shali S; Li C; Yang H; Huang Z; Ge J
    J Mol Cell Cardiol; 2020 May; 142():65-79. PubMed ID: 32087217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway.
    Zhang X; Du Q; Yang Y; Wang J; Dou S; Liu C; Duan J
    Biomed Pharmacother; 2017 Jul; 91():1042-1052. PubMed ID: 28525945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
    Valle Raleigh J; Mauro AG; Devarakonda T; Marchetti C; He J; Kim E; Filippone S; Das A; Toldo S; Abbate A; Salloum FN
    Cardiovasc Res; 2017 May; 113(6):609-619. PubMed ID: 28073832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation.
    Wang Y; Yan X; Mi S; Li Z; Wang Y; Zhu H; Sun X; Zhao B; Zhao C; Zou Y; Hu K; Ding X; Sun A; Ge J
    J Cell Mol Med; 2017 Jan; 21(1):4-12. PubMed ID: 27785882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the TLR4/Myd88/NF-κB Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury.
    Su Q; Li L; Sun Y; Yang H; Ye Z; Zhao J
    Cell Physiol Biochem; 2018; 47(4):1497-1508. PubMed ID: 29940584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2X
    Yin J; Wang Y; Hu H; Li X; Xue M; Cheng W; Wang Y; Li X; Yang N; Shi Y; Yan S
    J Cell Mol Med; 2017 Nov; 21(11):2695-2710. PubMed ID: 28470940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Puerarin protects against myocardial ischemia/reperfusion injury by inhibiting inflammation and the NLRP3 inflammasome: The role of the SIRT1/NF-κB pathway.
    Wang ZK; Chen RR; Li JH; Chen JY; Li W; Niu XL; Wang FF; Wang J; Yang JX
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107086. PubMed ID: 33068868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chicken cathelicidin-2 promotes IL-1β secretion via the NLRP3 inflammasome pathway and serine proteases activity in LPS-primed murine neutrophils.
    Peng L; Lu Y; Tian H; Jia K; Tao Q; Li G; Wan C; Ye C; Veldhuizen EJA; Chen H; Fang R
    Dev Comp Immunol; 2022 Jun; 131():104377. PubMed ID: 35189160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ghrelin protects the heart against ischemia/reperfusion injury via inhibition of TLR4/NLRP3 inflammasome pathway.
    Wang Q; Lin P; Li P; Feng L; Ren Q; Xie X; Xu J
    Life Sci; 2017 Oct; 186():50-58. PubMed ID: 28782532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uric acid aggravates myocardial ischemia-reperfusion injury via ROS/NLRP3 pyroptosis pathway.
    Shen S; He F; Cheng C; Xu B; Sheng J
    Biomed Pharmacother; 2021 Jan; 133():110990. PubMed ID: 33232925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective.
    Sandanger Ø; Gao E; Ranheim T; Bliksøen M; Kaasbøll OJ; Alfsnes K; Nymo SH; Rashidi A; Ohm IK; Attramadal H; Aukrust P; Vinge LE; Yndestad A
    Biochem Biophys Res Commun; 2016 Jan; 469(4):1012-20. PubMed ID: 26706279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-495 Ameliorates Cardiac Microvascular Endothelial Cell Injury and Inflammatory Reaction by Suppressing the NLRP3 Inflammasome Signaling Pathway.
    Zhou T; Xiang DK; Li SN; Yang LH; Gao LF; Feng C
    Cell Physiol Biochem; 2018; 49(2):798-815. PubMed ID: 30165354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.
    Niemi K; Teirilä L; Lappalainen J; Rajamäki K; Baumann MH; Öörni K; Wolff H; Kovanen PT; Matikainen S; Eklund KK
    J Immunol; 2011 Jun; 186(11):6119-28. PubMed ID: 21508263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury.
    Bei Y; Pan LL; Zhou Q; Zhao C; Xie Y; Wu C; Meng X; Gu H; Xu J; Zhou L; Sluijter JPG; Das S; Agerberth B; Sun J; Xiao J
    BMC Med; 2019 Feb; 17(1):42. PubMed ID: 30782145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of NLRP3 inflammasome activation and its role in NSAID-induced enteropathy.
    Higashimori A; Watanabe T; Nadatani Y; Takeda S; Otani K; Tanigawa T; Yamagami H; Shiba M; Tominaga K; Fujiwara Y; Arakawa T
    Mucosal Immunol; 2016 May; 9(3):659-68. PubMed ID: 26349656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cinnamic acid preserves against myocardial ischemia/reperfusion injury via suppression of NLRP3/Caspase-1/GSDMD signaling pathway.
    Luan F; Rao Z; Peng L; Lei Z; Zeng J; Peng X; Yang R; Liu R; Zeng N
    Phytomedicine; 2022 Jun; 100():154047. PubMed ID: 35320770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil NLRP3 promotes cardiac injury following acute myocardial infarction through IL-1β production, VWF release and NET deposition in the myocardium.
    Heger LA; Schommer N; Van Bruggen S; Sheehy CE; Chan W; Wagner DD
    Sci Rep; 2024 Jun; 14(1):14524. PubMed ID: 38914598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.